A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition
Clinical trial NCT04592822 · UNKNOWN
Trial details
- NCT number
- NCT04592822
- Sponsor
- Hong Kong WD Pharmaceutical Co., Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2021-06-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.